IBM, LLNL to Develop New Blue Gene Supercomputer; Commercialization to Follow | GenomeWeb

NEW YORK, Nov. 9 – IBM is partnering with the Department of Energy's National Nuclear Security Agency to develop Blue Gene/L, a 200-teraflop supercomputer that expands on the computer giant’s Blue Gene research project, the company announced on Friday. 

IBM and NNSA's Lawrence Livermore National Laboratory will jointly design Blue Gene/L, which IBM said will be 15 times faster, 15 times more power efficient, and will require about 50 times less space per computation than today's fastest supercomputers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.